AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00% AIX 9.01 ▲0.33% ALU 0.88 ▼-2.22% DN1 99.70 ▼-0.09% EMUCA 0.89 KIT 1.90 ▲0.00% KKC 2.11 ▲0.00% LF1 1.92 ▲0.79% MBG 0.14 ▲0.00% MRE 1.88 ▼-0.53% PCI 1.09 ▼-0.91% PCX 1.99 ▼-0.75% RF1 3.52 ▼-0.28% SET 2.14 ▼-0.47% TET 0.22 ▼-2.22% WMX 1.69 ▼-1.17% BST 0.30 ▲3.45% CTS 0.56 ▲1.82% EFR 0.00 ▲0.00%

FPH Fisher & Paykel Healthcare Corporation Limited

Healthcare · Medical Instruments & Supplies · website · 7,357 employees
$34.48
52wk 26.51 – 35.31
Overall
Value
Growth
Health
Quality
Momentum
Dividend
Price
About Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. The company provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. It also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation. In addition, the company provides infant respiratory products, such as resuscitation, invasive ventilation, continuous positive airway pressure (CPAP), and nasal high flow products. Further, it offers hospital products comprising humidification products, breathing circuits, chambers, masks, nasal cannulas, surgical, accessories, and interfaces; and homecare products that include masks, CPAP devices, software and data management products, and humidifiers. Fisher & Paykel Healthcare Corporation Limited was founded in 1934 and is headquartered in Auckland, New Zealand.

Fundamental trends
Financial statements
Loading…
Key metrics
Market cap
$20.25B
P/E (trailing)
52.24
P/E (forward)
37.96
EPS (trailing)
0.66
Dividend yield
1.3%
Payout ratio
54.0%
Beta
0.89
EV / EBITDA
25.88
Price / Book
11.48
ROE
23.4%
Operating margin
28.7%
Net margin
20.3%
Total cash
$461.10M
Total debt
$146.10M
Current ratio
2.31
Debt / Equity
0.07
Free cash flow
$399.41M
Avg volume
438,621
Latest annual results (FY ending 31 Mar 2026)
  • Revenue$2.31B
  • Gross profit$1.47B
  • Operating income$477.80M
  • Net income$468.50M
  • Diluted EPS0.79
  • Free cash flow$468.00M
  • Net debt-$315.00M
Sector peers (Healthcare)
TickerMkt cap P/EScore
CSL $59.53B 14.0
RMD $43.89B 20.4
SIG $34.28B 59.4
PME $17.21B 73.5
SHL $10.79B 19.7
RHC $10.13B 34.8
COH $7.90B 22.9
TLX $4.84B